Edition:
United Kingdom

AnaptysBio Inc (ANAB.OQ)

ANAB.OQ on NASDAQ Stock Exchange Global Select Market

82.62USD
15 Aug 2018
Change (% chg)

$-0.42 (-0.51%)
Prev Close
$83.04
Open
$80.76
Day's High
$83.66
Day's Low
$80.28
Volume
153,641
Avg. Vol
129,440
52-wk High
$134.00
52-wk Low
$20.12

Chart for

About

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro,... (more)

Overall

Beta: --
Market Cap(Mil.): $725.82
Shares Outstanding(Mil.): 20.34
Dividend: --
Yield (%): --

Financials

  ANAB.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.06 -- --
ROI: -23.31 1.78 14.61
ROE: -48.33 3.28 16.33

BRIEF-Anaptysbio Qtrly Loss Per Share $0.63

* ANAPTYSBIO ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES PIPELINE UPDATES

08 May 2018

BRIEF-Anaptysbio Announces Positive Top-Line Proof-Of-Concept Data For ANB020 In Moderate-To-Severe Baseline Adult Peanut Allergy Patients

* ANAPTYSBIO ANNOUNCES POSITIVE TOP-LINE PROOF-OF-CONCEPT DATA FOR ANB020 IN MODERATE-TO-SEVERE BASELINE ADULT PEANUT ALLERGY PATIENTS

26 Mar 2018

BRIEF-AnaptysBio Qtrly ‍Loss Per Share $0.30

* ANAPTYSBIO ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND 2018 PIPELINE MILESTONES

05 Mar 2018

Earnings vs. Estimates